Contribution of the Parties. The allocation of tasks, as defined by the Committee Product Subdivision and approved by the Parties pursuant to Article 5.02.(a) of the Frame Agreement, is that specified in Annex 2 hereto attached. Each Party will bear the expenses associated with its own tasks.
Contribution of the Parties. The Parties agree (without prejudice to their other obligations under this Agreement) that their contribution to the Business Cooperation Agreement shall be as followings:
Contribution of the Parties. 2.1.1 The Parties agree to duly cooperate as to the purpose of this Agreement in performing an investigation regarding the manufacturing of clinical samples and later commercial supplies of the Products, clinical trials and registration based on the Design and the manufacturing technology and know-how provided by BDSI regarding the Product including, but not limited to clinical trials and registration, all in accordance with and as to the extent further specified and provided in this Agreement.
2.1.2 Based on Technical Information as disclosed by BDSI, LTS shall use Commercially Reasonable Efforts to develop the Process to manufacture the Product for BDSI in accordance with the applicable Product Specifications and the Project Plan.
2.1.3 BDSI shall disclose to LTS all necessary BDSI Technology concerning formulation, ingredients and compounding ratio of the Product, the Product specification values, manufacturing method and other technology and know-how of the Product.
2.1.4 LTS shall use its Commercially Reasonable Efforts to supply quantities of Product to BDSI according to the Project Plan. All Products supplied by LTS hereunder shall: (a) conform to the Product Specifications; and (b) be manufactured, labelled, packaged and tested (while in the possession or control of LTS) in accordance with GMP and the applicable laws and regulations relating to the manufacture, labelling, packaging and testing of the Product.
2.1.5 LTS shall use its Commercially Reasonable Efforts to prepare as soon as possible those sections of any applicable regulatory documents of an Authority which concern the development of the Process or the manufacturing of the Product by LTS and shall provide those sections to BDSI as soon as possible for inclusion in any applicable regulatory filings with an Authority which concern the Product. To the extent disclosure of LTS’ proprietary information is required for such purposes, Section 10.7. shall govern.
2.1.6 BDSI shall provide LTS ****
2.1.7 To the extent required by law, BDSI shall use its Commercially Reasonable Efforts to ensure that LTS has the right to reasonably audit the supplier of the Active Principle for compliance with relevant regulatory requirements including GMP.
2.1.8 BDSI or its Affiliates or its licensees shall be responsible for the clinical trials, the registration of the Product with the proper health, customs and other Authorities, as applicable, to be carried out in BDSI’s sole discretion.
2.1.9 LTS shall only *...
Contribution of the Parties. X. XXX shall contribute to the Company its License Agreement dated as of January 1, 1996 in connection with the teen magazine supplement sometimes referred to as Xpress.
B. HCMI commits to contribute $4,737,500 cash ("Funding"), contingent on raising $12,500,000 in a public offering of HCMI common stock. HCMI commits to contribute up to an additional $6,862,500 if it raises $20,000,000 in a public offering of HCMI common stock.
Contribution of the Parties. (a) The contribution of the Consortium to the Contractual Joint Venture shall be in cash in the amount of the Project Costs. The Consortium’s Contribution shall be made in intervals as required by the Financing Documents.
(b) The contribution of MWSS to the Contractual Joint Venture shall include the items as detailed in Section 3.05 as well as cash, if required.
Contribution of the Parties. 4.1. Xxxx Xxxxxxx and Xxxxx Xxxxxxxxx agree to take all the necessary actions and execute any document or instrument in order to duly assign the patents set forth in Appendix C (the “Patents”) to the Company and to update all relevant authorities upon such transfer. The costs for patent maintenance paid by shai until now will be considered as a loan bearing same interest as the loan of Chirich (see below).
4.2. Chirich, by himself or through a controlled subsidiary company, shall contribute funds to ensure the operation of the Company pursuant to the Budget attached hereto as Appendix D. The said contribution shall be made by way of a loan bearing interest and payment terms as will be agreed between the Parties.
Contribution of the Parties. The contributions of the Parties to the Projects shall be as set out in Appendix B. Personnel and travel costs shall be borne by the respective Party itself.
Contribution of the Parties. 4.2.1 The investment by the Parties to the registered capital shall be contributed according to the following proportions: VENTURER IT shall contribute Euro (say: ), ac- counting for 60 % of the registered capital; VENTURER PRC shall contribute Euro (say: ), ac- counting for 40 % of the registered capital.
Contribution of the Parties. 1It is intended that each party shall contribute particular knowledge, skills or services to assist the establishment and success of the Alliance. The general responsibilities of each party are set in this Article 3.
Contribution of the Parties a. AEGOPL shall contribute and do the following:
i. Investment into EWSI of initially US$750,000, to be used as stated in the Use of Proceeds, detailed below; with such funds coming from qualified investors under SEC regulations: Proposed Use of Proceeds: • USD $500,000 for the acquisition of the target PubCo for the RTO • USD $250,000 as working capital for the development of e-waste projects in New York area
ii. EWSI will, in turn receive shares in the new PubCo, equal to 2.5% of the post-acquired PubCo common stock plus warrants in the PubCo to be negotiated under the formal Share Exchange Agreement associated with the RTO. .
iii. Enter into an exclusive contract with EWSI for the expansion of their New York e-waste recycling center. The Capital Investment required for this expansion will be made via the RTO Company and shall be a further $1.75M This investment will be subject to due diligence to be undertaken by the AEGOPL and it's investment partners and the new management of the PubCo
iv. Based on the successful collaboration on the New York project, the Parties would negotiate a Joint Venture agreement to establish regional and/or national eWaste recycling and environmental business(es) in India
b. EWSI shall contribute and do the following:
i. Shall offer AEGOPL investors securities in EWSI in one of the following forms, to be decided by the investor:
i. Restricted common stock at a 30% discount to the current 20 day volume weighted average price (‘VWAP’) per share with voting rights, or
ii. Series A Convertible Redeemable Preferred Shares priced at $1000/share with a 10% coupon to maturity, a 30% redemption premium, and option to convert, at a price of $1100, into common stock at a 25% discount to the 20 day VWAP with voting available upon conversion
iii. Series B Preferred Stock at $1000 per share with super voting rights and 25% redemption premium but no conversion rights
iv. Convertible Debenture with 10% interest and the right to convert to free trading shares after 180 days at a price of 30% discount to the 20 day VWA
ii. Shall allow its fully licensed and permitted eWaste recycling operation in the State of New York, USA to become the platform for the Project, including its customer base, its facility, its inventory, its know-how, and its employees and management in the NY facility
iii. Provide such managerial and professional support for the Project required to at least maintain its current credentials, including ISO 9001, ISO 14001, R2, Ne...
